Abstract:Background: Relationships between migraine improvement after transcatheter patent foramen ovale (PFO) closure and both specific interatrial septum anatomy and different devices design have not been investigated yet. We sought to assess effectiveness of transcatheter PFO closure in reducing or curing migraine with aura in patients with previous paradoxical embolism in relation with specific interatrial septum anatomy and different closure devices.Methods and Results: We prospectively enrolled 34 patients (22 female and 12 male, mean age 40 +/- 3.7 years) who were referred to our centre over a 12-month period for PFO transcatheter closure and migraine with aura and previous paradoxical embolism. All procedures were performed using mechanical intracardiac echocardiographic guidance. Patients were assigned to Amplatzer PFO or ASD Multifenestrated Occluder and Premere Occlusion System implantation dependently from intracardiac echocardiography anatomical findings, which included short-channel with moderate atrial septal aneurysm (ASA) in 6 patients (17.6 %), long-channel with moderate ASA in 3 patients (8.8%), short-channel with huge ASA in 5 patients (14.7%), multifenestrated ASA in 4 patients (11.7%), long-channel PFO without ASA in 10 patients (29.4%), and long-channel PFO with mild ASA in 6 patients (17.6%). Accordingly, 18 patients received an Amplatzer Occluder (9 PFO Occluder and 7 ASD Multifenestrated Occluder), and 16 received a Premere Occlusion System. After a mean follow-up of 9.0 +/- 2.8 months, all patients improved their migraine symptoms (mean Migraine Disability Assessment Score 30 +/- 1.5 at baseline versus 6.0 +/- 2.9 in the follow up, P<.03) independently from specific interatrial septum anatomy and different closure devices.Conclusion: Although our study had several limitations, it suggests that independently from interatrial septum anatomy and device type, PFO closure in patients with migraine with aura resulted in a high rate of migraine improvement. (C) 2010 Elsevier Inc. All rights reserved.

Transcatheters for Closure of Patent Foramen Ovales

Transcatheters for Closure of Patent Foramen Ovales.

Recent Advances in Catheter Devices for Patent Foramen Ovale Closure

Patent Foramen Ovale: a Comprehensive Review for Pulmonologists

Patent Oval Foramen Transcatheter Closure: Results of A Strategy Based on Tailoring the Device to the Specific Patient'S Anatomy

Patent Foramen Ovale: the Evident Paradox Between the Apparently Simple Treatment and the Really Complex Pathophysiology

Patent Foramen Ovale with Paradoxical Embolism: Mid‐Term Results of Transcatheter Closure in 256 Patients

Asymptomatic Significant Patent Foramen Ovale: Giving Patent Foramen Ovale Management Back to the Cardiologist

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.

Premere Occlusion System for Transcatheter Patent Foramen Ovale Closure: Mid‐term Results of a Single‐center Registry

Safety and Long-Term Results of Patent Foramen Ovale Transcatheter Closure in Patients with Thrombophilia.

Interatrial Shunts: Technical Approaches to Percutaneous Closure

Transcatheter Patent Foramen Ovale Closure is Effective in Reducing Migraine Independently from Specific Interatrial Septum Anatomy and Closure Devices Design.

[Patent Foramen Ovale: a Benign Anatomical Variant That Can Become a Disease].

Anatomo-functional Characterization of Interatrial Septum for Catheter-Based Interventions.

Transcatheter PFO closure for cryptogenic stroke: current approaches and future considerations

Differences and Similarities in Interatrial Shunts Management.

Impact of Interatrial Septum Anatomic Features on Short- and Long-Term Outcomes after Transcatheter Closure of Patent Foramen Ovale: Single Device Type Versus Anatomic-Driven Device Selection Strategy

ICE-guided Patent Foramen Ovale (PFO) Closure with Lastest-Generation Devices: the Ideal Strategy for PFO-related Migraine?

Patent Foramen Ovale Closure for Nonstroke Indications